← Leaderboards
Alison M Goate
Icahn School Of Medicine At Mount Sinai
$50,419,418
Attributed
$84,843,526
Total exposure
33
Grants
26
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $19.3M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$126,945,601 · 35
By mechanism
U19$35,737,499 · 4
U24$27,247,663 · 1
U01$22,696,573 · 6
R01$15,138,485 · 5
U54$13,732,311 · 5
RF1$4,223,847 · 1
Top collaborators
- Carlos Cruchaga11 shared
- Tatiana M. Foroud10 shared
- Richard Mayeux10 shared
- Daniel H Geschwind9 shared
- Martin Kampmann8 shared
- Bin Zhang6 shared
- David M Holtzman5 shared
- William J Ray5 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Francesca Garretti$224,404
- Marta Filizola$11,220,258
- Jeremiah James Faith$16,695,707
- Vahram Haroutunian$39,970,462
- Eric E Schadt$18,256,361
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposGeneticGenesS DiseaseVariantAllelesGenome Wide Association StudyGenotypeMutationBaseCellsGene ExpressionMolecularBrainInduced Pluripotent Stem CellResearch PersonnelIn VivoTau ProteinsCommunitiesS Disease RiskDisorder RiskDementiaData SetResources
Grant awards (142)
Biology and pathobiology of apoE in aging and Alzheimer's disease$6,293,390
U19 · FY2025 · AG
National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS)$4,491,049
U24 · FY2025 · AG
Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP$1,827,905
U54 · FY2025 · NS · contact PI
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease$1,159,438
R01 · FY2025 · AG · contact PI
Therapeutic effects of APOE regulation via LNP-RNA formulations in Alzheimer's disease$835,417
R01 · FY2025 · AG
Genetic modifiers of APOE-related risk for AD$676,279
U19 · FY2025 · AG · contact PI
Project 1: Determination of molecular differences caused by tauopathy-associated H1 and H2 haplotypes$648,438
U54 · FY2025 · NS · contact PI
A Precision Medicine Approach for the Study of Targetable Pathways in Vascular Dementia$312,652
R01 · FY2025 · AG · contact PI
Core A: Administrative$141,040
U54 · FY2025 · NS · contact PI
Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP$83,873
U54 · FY2025 · NS · contact PI
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP$55,916
U54 · FY2025 · NS · contact PI
Biology and pathobiology of apoE in aging and Alzheimer's disease$6,474,838
U19 · FY2024 · AG
National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS)$4,510,753
U24 · FY2024 · AG
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP$1,834,302
U54 · FY2024 · NS · contact PI
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease$1,585,167
U01 · FY2024 · AG
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease$1,191,261
R01 · FY2024 · AG · contact PI
Project 1: Determination of molecular differences caused by tauopathy-associated H1 and H2 haplotypes$711,491
U54 · FY2024 · NS · contact PI
Genetic modifiers of APOE-related risk for AD$510,063
U19 · FY2024 · AG · contact PI
Core A: Administrative$145,871
U54 · FY2024 · NS · contact PI
Biology and pathobiology of apoE in aging and Alzheimer's disease$6,523,942
U19 · FY2023 · AG
National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS)$4,502,386
U24 · FY2023 · AG
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP$1,827,156
U54 · FY2023 · NS · contact PI
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease$1,584,706
U01 · FY2023 · AG
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease$1,199,181
R01 · FY2023 · AG · contact PI
Project 1: Determination of molecular differences caused by tauopathy-associated H1 and H2 haplotypes$716,379
U54 · FY2023 · NS · contact PI
Genetic modifiers of APOE-related risk for AD$581,645
U19 · FY2023 · AG · contact PI
Core A: Administrative$145,871
U54 · FY2023 · NS · contact PI
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP$37,683
U54 · FY2023 · NS · contact PI
Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP$23,687
U54 · FY2023 · NS · contact PI
Biology and pathobiology of apoE in aging and Alzheimer's disease$6,571,383
U19 · FY2022 · AG
National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS)$4,714,038
U24 · FY2022 · AG
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP$1,834,889
U54 · FY2022 · NS · contact PI
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease$1,587,671
U01 · FY2022 · AG
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease$1,224,125
R01 · FY2022 · AG · contact PI
Genomic approach to identification of microglial networks involved in Alzheimer disease risk$835,533
U01 · FY2022 · AG · contact PI
Project 1: Determination of molecular differences caused by tauopathy-associated H1 and H2 haplotypes$716,539
U54 · FY2022 · NS · contact PI
The Familial Alzheimer Sequencing (FASe) Project$669,813
U01 · FY2022 · AG
Genetic modifiers of APOE-related risk for AD$581,645
U19 · FY2022 · AG · contact PI
Genetics and Genomics Core$365,862
P30 · FY2022 · AG · contact PI
Core A: Administrative$145,870
U54 · FY2022 · NS · contact PI
2022 Neurobiology of Brain Disorders GRC and GRS$49,998
R13 · FY2022 · AG · contact PI
Biology and pathobiology of apoE in aging and Alzheimer's disease$6,820,292
U19 · FY2021 · AG
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP$1,892,819
U54 · FY2021 · NS · contact PI
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)$1,663,171
U24 · FY2021 · AG
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease$1,595,511
U01 · FY2021 · AG
Genomic approach to identification of microglial networks involved in Alzheimer disease risk$852,908
U01 · FY2021 · AG · contact PI
Project 1: Determination of molecular differences caused by tauopathy-associated H1 and H2 haplotypes$776,527
U54 · FY2021 · NS · contact PI
The Familial Alzheimer Sequencing (FASe) Project$688,713
U01 · FY2021 · AG
Genetic modifiers of APOE-related risk for AD$610,676
U19 · FY2021 · AG · contact PI
Genetics and Genomics Core$495,607
P30 · FY2021 · AG · contact PI
Core A: Administrative$166,055
U54 · FY2021 · NS · contact PI
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)$1,680,616
U24 · FY2020 · AG
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease$1,623,635
U01 · FY2020 · AG
Genomic approach to identification of microglial networks involved in Alzheimer disease risk$948,483
U01 · FY2020 · AG · contact PI
The Familial Alzheimer Sequencing (FASe) Project$767,025
U01 · FY2020 · AG
Identification and characterization of AD risk networks using multi-dimensional "omics" data$756,361
U01 · FY2020 · AG · contact PI
Genetics and Genomics Core$365,862
P30 · FY2020 · AG · contact PI
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)$1,701,507
U24 · FY2019 · AG
Genomic approach to identification of microglial networks involved in Alzheimerâs disease risk$844,934
U01 · FY2019 · AG · contact PI
Identification and characterization of AD risk networks using multi-dimensional "omics" data$762,158
U01 · FY2019 · AG · contact PI
The Familial Alzheimer Sequencing (FASe) Project$699,383
U01 · FY2019 · AG
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)$405,000
U24 · FY2019 · AG
Genomic approach to identification of microglial networks involved in Alzheimerâs disease risk$361,706
U01 · FY2019 · AG · contact PI
Identification and characterization of AD risk networks using multi-dimensional "omics" data$336,850
U01 · FY2019 · AG · contact PI
Role of genomic imprinting in the etiology of Alcohol Dependence$243,656
R21 · FY2019 · AA · contact PI
Genomic approach to identification of microglial networks involved in Alzheimerâs disease risk$109,226
U01 · FY2019 · AG · contact PI
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)$1,716,428
U24 · FY2018 · AG
Genomic approach to identification of microglial networks involved in Alzheimerâs disease risk$846,895
U01 · FY2018 · AG · contact PI
Identification and characterization of AD risk networks using multi-dimensional "omics" data$793,195
U01 · FY2018 · AG · contact PI
The Familial Alzheimer Sequencing (FASe) Project$637,243
U01 · FY2018 · AG
Core G: Genetics$182,391
P50 · FY2018 · AG · contact PI
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)$1,862,715
U24 · FY2017 · AG
Identification and characterization of AD risk networks using multi-dimensional "omics" data$798,417
U01 · FY2017 · AG · contact PI
Modifier Genes that Influence Age at Onset or Protect Against Development of Alzheimer's Disease (AD)$477,281
U01 · FY2017 · AG · contact PI
Genetics and Genomics$215,840
P50 · FY2017 · AG · contact PI
Core G: Genetics$182,140
P50 · FY2017 · AG · contact PI
Understanding the mechanism of SPl1 dependent Alzheimer disease risk$4,223,847
RF1 · FY2016 · AG · contact PI
Identification and characterization of AD risk networks using multi-dimensional "omics" data$1,011,330
U01 · FY2016 · AG · contact PI
Modifier Genes that Influence Age at Onset or Protect Against Development of Alzheimer's Disease (AD)$477,281
U01 · FY2016 · AG · contact PI
Modifier Genes that Influence Age at Onset or Protect Against Development of Alzheimer's Disease (AD)$462,962
U01 · FY2015 · AG · contact PI
Core G: Genetics$181,585
P50 · FY2015 · AG · contact PI
Modifier Genes that Influence Age at Onset or Protect Against Development of Alzheimer's Disease (AD)$429,413
U01 · FY2014 · AG · contact PI
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes$404,749
R01 · FY2014 · AG · contact PI
DIAN Genetics Core$256,273
UF1 · FY2014 · AG · contact PI
ALZHEIMER'S DISEASE RESEARCH CENTER, GENETICS CORE$213,730
P50 · FY2014 · AG · contact PI
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes$48,785
R01 · FY2014 · AG · contact PI
DIAN Genetics Core$9,757
U19 · FY2014 · AG · contact PI
DIAN Genetics Core$9,754
U19 · FY2014 · AG · contact PI
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes$446,269
R01 · FY2013 · AG · contact PI
ALZHEIMER'S DISEASE RESEARCH CENTER, GENETICS CORE$199,003
P50 · FY2013 · AG · contact PI
SEQUENCE VARIATION IN GENES FOR BIOMAKERS PROTEINS AND AGE/ONSET ALZHEIMER'S DIS$108,935
P01 · FY2013 · AG · contact PI
DIAN Genetics Core$7,065
U19 · FY2013 · AG · contact PI
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes$566,166
R01 · FY2012 · AG · contact PI
GENETIC AND FUNCTIONAL ANALYSIS OF RISK ALLEIES FOR NICOTINE DEPENDENCE$262,606
P01 · FY2012 · CA · contact PI
ALZHEIMER'S DISEASE RESEARCH CENTER, GENETICS CORE$205,197
P50 · FY2012 · AG · contact PI
SEQUENCE VARIATION IN GENES FOR BIOMAKERS PROTEINS AND AGE/ONSET ALZHEIMER'S DIS$127,570
P01 · FY2012 · AG · contact PI
DIAN Genetics Core$8,319
U19 · FY2012 · AG · contact PI
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes$411,228
R01 · FY2011 · AG · contact PI
GENETIC AND FUNCTIONAL ANALYSIS OF RISK ALLEIES FOR NICOTINE DEPENDENCE$240,820
P01 · FY2011 · CA · contact PI
ALZHEIMER'S DISEASE RESEARCH CENTER, GENETICS CORE$205,466
P50 · FY2011 · AG · contact PI
SEQUENCE VARIATION IN GENES FOR BIOMAKERS PROTEINS AND AGE/ONSET ALZHEIMER'S DIS$101,168
P01 · FY2011 · AG · contact PI
Translational Neuroscientist and the Hope Center$692,958
P30 · FY2010 · NS · contact PI
GENOMIC SEARCH FOR SUSCEPTIBILITY TO ALZHEIMER DISEASE$502,346
R01 · FY2010 · AG · contact PI
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes$406,526
R01 · FY2010 · AG · contact PI
GENETIC AND FUNCTIONAL ANALYSIS OF RISK ALLEIES FOR NICOTINE DEPENDENCE$350,510
P01 · FY2010 · CA · contact PI
ALZHEIMER'S DISEASE RESEARCH CENTER, GENETICS CORE$210,513
P50 · FY2010 · AG · contact PI
SEQUENCE VARIATION IN GENES FOR BIOMAKERS PROTEINS AND AGE/ONSET ALZHEIMER'S DIS$179,376
P01 · FY2010 · AG · contact PI
DIAN Genetics Core$58,451
U19 · FY2010 · AG · contact PI
Translational Neuroscientist and the Hope Center$682,000
P30 · FY2009 · NS · contact PI
GENOMIC SEARCH FOR SUSCEPTIBILITY TO ALZHEIMER DISEASE$630,144
R01 · FY2009 · AG · contact PI
GENETIC AND FUNCTIONAL ANALYSIS OF RISK ALLEIES FOR NICOTINE DEPENDENCE$561,483
P01 · FY2009 · CA · contact PI
SEQUENCE VARIATION IN GENES FOR BIOMAKERS PROTEINS AND AGE/ONSET ALZHEIMER'S DIS$162,534
P01 · FY2009 · AG · contact PI
DIAN Genetics Core$78,878
U01 · FY2009 · AG · contact PI
GENETIC AND FUNCTIONAL ANALYSIS OF RISK ALLEIES FOR NICOTINE DEPENDENCE$369,535
P01 · FY2008 · CA · contact PI
DIAN Genetics Core$73,895
U01 · FY2008 · AG · contact PI
Genomic Search for Susceptibility to Alzheimer Disease$19,073
R01 · FY2008 · AG · contact PI
Genomic Search for Susceptibility to Alzheimer Disease$552,029
R01 · FY2007 · AG · contact PI
The Role of Cholesterol in Alzheimer's Disease$38,231
R03 · FY2007 · TW · contact PI
Genomic Search for Susceptibility to Alzheimer Disease$570,340
R01 · FY2006 · AG · contact PI
Genomic Search for Susceptibility to Alzheimer Disease$88,121
R01 · FY2006 · AG · contact PI
The Role of Cholesterol in Alzheimer's Disease$39,372
R03 · FY2006 · TW · contact PI
Genomic Search for Susceptibility to Alzheimer Disease$554,996
R01 · FY2005 · AG
GENETICS$110,000
P50 · FY2005 · AG
The Role of Cholesterol in Alzheimer's Disease$40,320
R03 · FY2005 · TW
Genomic Search for Susceptibility to Alzheimer Disease$540,366
R01 · FY2004 · AG
Genomic Search for Susceptibility to Alzheimer Disease$533,985
R01 · FY2003 · AG
ROLE OF PRESENILIN IN NOTCH AND APP MATURATION$288,572
R01 · FY2003 · AG
Genomic Search for Susceptibility to Alzheimer Diseae$153,000
R01 · FY2003 · AG
GENOMIC SEARCH FOR SUSCEPTIBILITY--ALZHEIMER DISEASE$590,277
R01 · FY2002 · AG
ROLE OF PRESENILIN IN NOTCH AND APP MATURATION$280,170
R01 · FY2002 · AG
Identification of genes that modify age of onset of AD$0
P50 · FY2002 · AG
Identification of genes that modify age of onset of AD$0
P50 · FY2002 · AG
Identification of genes that modify age of onset of AD$0
P50 · FY2002 · AG
GENOMIC SEARCH FOR SUSCEPTIBILITY--ALZHEIMER DISEASE$575,193
R01 · FY2001 · AG
ROLE OF PRESENILIN IN NOTCH AND APP MATURATION$272,011
R01 · FY2001 · AG
Identification of genes that modify age of onset of AD$264,341
P50 · FY2001 · AG
Identification of genes that modify age of onset of AD$0
P50 · FY2001 · AG
Identification of genes that modify age of onset of AD$0
P50 · FY2001 · AG
Identification of genes that modify age of onset of AD$0
P50 · FY2001 · AG
GENOMIC SEARCH FOR SUSCEPTIBILITY--ALZHEIMER DISEASE$517,979
R01 · FY2000 · AG
Identification of genes that modify age of onset of AD$264,341
P50 · FY2000 · AG
ROLE OF PRESENILIN IN NOTCH AND APP MATURATION$264,086
R01 · FY2000 · AG